Your browser doesn't support javascript.
Incidence and mortality risk in coronavirus disease 2019 patients complicated by acute cardiac injury: systematic review and meta-analysis.
Zuin, Marco; Rigatelli, Gianluca; Zuliani, Giovanni; Bilato, Claudio; Zonzin, Pietro; Roncon, Loris.
  • Zuin M; Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara.
  • Rigatelli G; Department of Cardiology, Santa Maria della Misericordia Hospital, Rovigo, Italy.
  • Zuliani G; Department of Cardiology, Section of Cardiovascular and Endoluminal interventions, Santa Maria della Misericordia Hospital, Rovigo.
  • Bilato C; Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara.
  • Zonzin P; Department of Cardiology, Ospedali dell'Ovest Vicentino, Arzignano.
  • Roncon L; Department of Cardiology, Santa Maria della Misericordia Hospital, Rovigo, Italy.
J Cardiovasc Med (Hagerstown) ; 21(10): 759-764, 2020 10.
Article in English | MEDLINE | ID: covidwho-1105976
ABSTRACT

BACKGROUND:

The prevalence and prognostic implications of acute cardiac injury (ACI), as a complication of coronavirus disease 2019 (COVID-19), remain unclear.

OBJECTIVES:

We conducted a systematic review and meta-analysis to investigate the relationship between ACI and mortality risk in COVID-19 patients.

METHODS:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed in abstracting data and assessing validity. We searched MEDLINE, Scopus and Web of Science to locate all articles published up to 10 April 2020 reporting data of COVID-19 survivors and nonsurvivors developing ACI as a complication of the infection. Quality assessment was performed using the Newcastle-Ottawa quality assessment scale. Data were pooled using the Mantel-Haenszel random effects models with odds ratio as the effect measure with the related 95% confidence interval. Statistical heterogeneity between groups was measured using the Higgins I statistic.

RESULTS:

Eight studies, enrolling 1686 patients (mean age 59.5 years), met the inclusion criteria and were included in the final analysis. Data regarding the outcome of patients complicated with ACI were available for 1615 patients. Of these, 387 (23.9%) experienced ACIs as COVID-19 complications during the hospitalization. The incidence of ACI was significantly higher among non survivors when compared with survivors (61.6 vs. 6.7%, P < 0.0001). The pooled analysis confirmed a significantly increased risk of death in COVID-19 patients complicated with ACI during the disease (odds ratio 21.6, 95% confidence interval 8.6-54.4, P < 0.0001, I = 82%).

CONCLUSION:

Development of ACI during COVID-19 significantly increases the risk of death during the infection.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Heart Diseases Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Topics: Long Covid Limits: Humans / Middle aged Language: English Journal: J Cardiovasc Med (Hagerstown) Journal subject: Vascular Diseases / Cardiology Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Heart Diseases Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Topics: Long Covid Limits: Humans / Middle aged Language: English Journal: J Cardiovasc Med (Hagerstown) Journal subject: Vascular Diseases / Cardiology Year: 2020 Document Type: Article